Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment. Take 2 mins to learn more.

News & Insights

Dr Ian Gilham appointed as new Chair of Cytox

Ian started his career developing novel diagnostics at Celltech and has held further posts developing diagnostics at Amersham International, Abbott Laboratories and GlaxoSmithKline, before becoming CEO of Axis-Shield. During his tenure he managed the sale of the business to Alere in 2011 for £250m.